[4-[6-[[5-Fluoro-4-(2-methyl-3-propan-2-ylindazol-5-yl)pyrimidin-2-yl]amino]-3-pyridinyl]piperazin-2-yl]methanol

InChIKey	`CRRKUTPFXCLRFN-UHFFFAOYSA-N`
Compound Name	[4-[6-[[5-Fluoro-4-(2-methyl-3-propan-2-ylindazol-5-yl)pyrimidin-2-yl]amino]-3-pyridinyl]piperazin-2-yl]methanol
Canonical SMILES	`CC(C)c1c2cc(-c3nc(Nc4ccc(N5CCNC(CO)C5)cn4)ncc3F)ccc2nn1C`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	3
Pfam Stratification	Cross-Family
Avg pChEMBL	9.18
Source	ChEMBL

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P11802	CDK4	Homo sapiens	Human	PF00069	9.2	IC50	ChEMBL
P24385	CCND1	Homo sapiens	Human	PF02984 PF00134	9.2	IC50	ChEMBL
Q00534	CDK6	Homo sapiens	Human	PF00069	9.1	IC50	ChEMBL